U-relaxStrain patent protection :
U-relax is licensed from Chr Hansen A / S and is under related patent protection by Urex Biotech inc. & Biogaia AB "WO 00/35465" & "WO 88/08452". The strains, GR-1 and RC-14, are both recommended by WHO. Please enter GR-1 and RC-14 to search related clinical information on PubMed website. Strains Manufacturing: Manufactured by the world's leading probiotics company, Chr Hansen from Demark, according to the EU EMMA pharmaceutical GMP standard. |
Muco-relaxStrain patent protection :
Muco-relax capsule is licensed from Chr Hansen A / S with uniq manufacturing of Probio-Tec BG-Vcap-6.5 in accordance with EU EMMA pharmaceutical GMP standard. Strain and content: LGG, Lactobacillus rhamnosus GG and BB-12, Bifidobacterium lactis BB12, each capsule contains 7 billion CFU. Please enter LGG and BB-12 to search related clinical information on PubMed website. |
I-relaxStrain patent protection :
I-relax is licensed from Chr Hansen A / S with uniq manufacturing of Probio-Tec BB- 12 SBlend - 2.5 FOS V1 in accordance with EU EMMA pharmaceutical GMP standard. Strain and content : BB- 12, Bifidobacterium lactis BB12, each containing 15 billion CFU and FOS, Fructo-oligosaccharide, 4.2 g . |
Chr. Hansen A/S is a global company based in Hørsholm, Denmark which produces natural ingredients for the food, beverage, dietary supplements and agricultural industry. The company is a supplier of food cultures, probiotics, enzymes and natural colors. Its products are used in cheese production, fermented milk, meat, food service, beverages, wine, fruit preparation, ice and desserts, confectionery, cereals, spreads, bakery products, snacks, dietary supplements, pharmaceuticals and agricultural products. Chr. Hansen A/S has development centers in Denmark, the United States, France and Germany including research facilities in Denmark and France. A large percentage of the employees engage in research and development for the international food and pharmaceuticals industry.
|
Probiotics are microorganisms that are believed to provide health benefits when consumed.The term probiotic is currently used to name ingested microorganisms associated with beneficial effects to humans and animals.The term came into more common use after 1980. The introduction of the concept is generally attributed to recipient Élie Metchnikoff, who in 1907 suggested that "the dependence of the intestinal microbes on the food makes it possible to adopt measures to modify the flora in our bodies and to replace the harmful microbes by useful microbes". A significant expansion of the potential market for probiotics has led to higher requirements for scientific substantiation of putative beneficial effects conferred by the microorganisms.Studies on the medical benefits of probiotics have yet to reveal a cause-effect relationship, and their medical effectiveness has yet to be conclusively proven for most of the studies conducted thus far.
|